Recruiting High Cholesterol Studies in Vienna
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
This is a pivotal phase III study designed to evaluate safety, tolerability, and efficacy of inclisiran in children (aged 6 to \<12 years) with heterozygous familial hypercholesterolemia (HeFH) and el...
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
This is a pivotal phase III study designed to evaluate safety, tolerability, and efficacy of inclisiran in children (aged 2 to \<12 years) with homozygous familial hypercholesterolemia (HoFH) and elev...
About High Cholesterol Clinical Trials in Vienna
High cholesterol occurs when there is too much cholesterol in the blood, increasing the risk of heart disease and stroke. It has no symptoms and is detected through blood tests. Management includes diet changes, exercise, and medications such as statins.
There are currently 2 high cholesterol clinical trials recruiting participants in Vienna, . These studies are seeking a combined 60 participants. Research is being sponsored by Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
High Cholesterol Clinical Trials in Vienna — FAQ
Are there high cholesterol clinical trials in Vienna?
Yes, there are 2 high cholesterol clinical trials currently recruiting in Vienna, . Browse the studies on this page to find one that fits.
How do I join a clinical trial in Vienna?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Vienna research site will contact you about next steps.
Are clinical trials in Vienna free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Vienna studies also compensate for your time and travel.
What high cholesterol treatments are being tested?
The 2 active trials in Vienna are testing new therapies including novel drugs, biologics, and treatment approaches for high cholesterol.
Data updated March 2, 2026 from ClinicalTrials.gov